Serena Travaglini
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
The role of Bladder EpiCheck® test in predicting residual tumor after transurethral resection of bladder cancer: Results from a pilot study.
Journal: Urologia
Published: April 17, 2026
Metabolic Signature of FLT3-Mutated AML: Clinical and Therapeutic Implications.
Journal: Journal of personalized medicine
Published: June 26, 2025
PML::RARα+ myeloid cells display metabolic alterations that can be targeted to treat resistant/relapse acute promyelocytic leukemias.
Journal: Leukemia
Published: March 21, 2025
Combination Treatment of Resistant Acute Promyelocytic Leukemia Cells with Arsenic Trioxide and Anti-Apoptotic Gene Inhibitors.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 25, 2024
Advances in the pathogenesis of FLT3 -mutated acute myeloid leukemia and targeted treatments.
Journal: Current opinion in oncology
Published: September 09, 2024
Evolution of transcriptomic profiles in relapsed inv(16) acute myeloid leukemia.
Journal: Leukemia research
Published: June 03, 2024
Therapy-Related Myeloid Neoplasm: Biology and Mechanistic Aspects of Malignant Progression.
Journal: Biomedicines
Published: April 01, 2024
Characterization of a novel IDH2-R159H mutation in acute myeloid leukaemia: Effects on cell metabolism and differentiation.
Journal: British journal of haematology
Published: September 19, 2023
YY1 Knockdown Relieves the Differentiation Block and Restores Apoptosis in AML Cells.
Journal: Cancers
Published: June 19, 2023
Functional characterization and response to FLT3 inhibitors in acute myeloid leukaemia with a non-canonical FLT3 mutation: A proof of concept.
Journal: British journal of haematology
Published: June 08, 2023
Last Updated: 09/26/2026